Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

RapidDiag

Financiado

Cerrado

Development of a compatible nanoparticle based rapid and sensitive diagnostic pl...

Development of a compatible nanoparticle based rapid and sensitive diagnostic platform for microbial infections LIG Biowise Ltd specialises in the development of targeted nanodrugs and targeted nanodiagnostic systems. The company is now developing a next generation rapid diagnostic system for use by healthcare staff to quickly determine whe... ver más

31/08/2018

LIG Biowise

70K€

Presupuesto del proyecto: 70K€

Líder del proyecto

LIG BIOWISE LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-08-31

INNOSUP-02-2016: European SME innovation Associate -...

I+D

Cerrada hace 8 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

LIG Biowise

70.19K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RTI2018-099019-A-I00 DESARROLLO DE TECNOLOGIAS DE FLUJO CONTINUO BASADAS EN SISTE... 128K€ Cerrado

PID2020-114347RB-C31 DISEÑO Y SINTESIS DE NANOPARTICULAS MOLECULARES Y BIOMOLECUL... 133K€ Cerrado

NANOTESTS Fabrication and development of nanotoxicology test bacterial... 224K€ Cerrado

PLEC2021-007739 Biosensores nanofotónicos para el diagnóstico y gestión clín... 370K€ Cerrado

BIO2014-61515-EXP ANTIBIOTICOS VIVOS FRENTE A PATOGENOS INTRACELULARES 30K€ Cerrado

FORMAMP Innovative Nanoformulation of Antimicrobial Peptides to Trea... 10M€ Cerrado

Duración del proyecto: 18 meses Fecha Inicio: 2017-02-28
Fecha Fin: 2018-08-31

Líder del proyecto

LIG BIOWISE LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 70K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto LIG Biowise Ltd specialises in the development of targeted nanodrugs and targeted nanodiagnostic systems. The company is now developing a next generation rapid diagnostic system for use by healthcare staff to quickly determine whether medical symptoms are a viral infection or bacterial infection. Many infectious diseases present with similar symptoms and it can be difficult to correctly diagnose and treat a patient without further diagnostic investigation. Infectious diseases are one of the major cases of global morbidity and mortality, resulting in 16.2% of all deaths per year. The majority of these infectious diseases are a result of viral or bacterial pathogens. It is estimated that in the UK alone, over 10 million needless antibiotic prescriptions are written each year. This number includes prescriptions incorrectly given to patients suffering from viral infections. This is not only a waste of financial resources, but also leads to the development of drug resistant bacteria strains. This trend has been repeated worldwide, meaning that antibiotics are losing their effectiveness at an increasing rate and antibiotic resistance has become a worldwide problem. A diagnostic kit, such as the product proposed by LIG Biowise, will save millions of euros in costs associated with the over prescription of antibiotics for viral infections and lead to reductions in the number of drug resistant bacteria. LIG Biowise’s rapid medical diagnostic kit will give healthcare staff a rapid diagnosis, while remaining technologically simple, have minimal training requirements and will not require expensive instrumentation. The SME Innovation Associate will play a crucial role in helping LIG Biowise reach this goal. They will also undertake a 12-month training programme, including; a mentoring scheme with academic and industrial leaders, opportunities to attend conferences, and full participation in EU core training programme.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores